A. Lebrun

Successful treatment with rituximab in a patient with an acquired factor V inhibitor

M. Michel, C. Leroy-Matheron, J. Arlet, 2008, American journal of hematology.

COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study

Julie M. Woessner, P. Hennequin, Cécile Paris, 2021, The Lancet Rheumatology.

Factors Associated with Severe Skin Infections in Patients Treated with Biologic Therapies for Inflammatory Rheumatic Diseases

M. Dougados, N. Dupin, C. Salliot, 2012, Dermatology.

Psoas abscess: An unusual manifestation of Q fever.

M. Michel, B. Godeau, L. Deforges, 2007, European journal of internal medicine.

Challenges of Cardiovascular Risk Assessment in the Routine Rheumatology Outpatient Setting: An Observational Study of 110 Rheumatoid Arthritis Patients

M. Dougados, L. Gossec, P. Boumier, 2013, Arthritis care & research.

Evaluation of collected outcome measures in axial spondyloarthritis in daily-care rheumatology settings: the experience of the RHEVER network.

M. Dougados, P. Boumier, E. Dernis, 2015, Clinical and Experimental Rheumatology.

Evaluation of Usability and Acceptance of a New Autoinjector Intended for Methotrexate Subcutaneous Self-Administration in the Management of Rheumatoid Arthritis

Elena Zinovieva, Christophe Hudry, Agnès Lebrun, 2017, Rheumatology and Therapy.

T.5. Th1 versus Th17 Cells in Ankylosing Spondylitis

M. Dougados, L. Rogge, L. Gossec, 2009 .